Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis.

Name: Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis.
Author: Mascarenhas, John

Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis. — المؤلف: Mascarenhas, John — Leukemia & lymphoma 20200713

المؤلف: Mascarenhas, John
النشر: Leukemia & lymphoma 20200713
الوصف: 1343-1345 p.
الموضوعات: Carbazoles؛ Furans؛ Humans؛ Janus Kinase 2؛ Janus Kinase Inhibitors؛ Primary Myelofibrosis؛ Treatment Outcome